Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy (I-BrEATHe)

Clinical Trial ID NCT04050371

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04050371

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.	N Engl J Med	2010	50.17
2	Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.	Sci Transl Med	2012	6.29
3	Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco.	PLoS One	2011	1.84
4	Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus.	Ann Behav Med	2014	1.46
5	"There's no pamphlet for the kind of sex I have": HIV-related risk factors and protective behaviors among transgender men who have sex with nontransgender men.	J Assoc Nurses AIDS Care	2009	1.31
6	HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.	Lancet HIV	2015	1.31
7	Electronic medical records and the transgender patient: recommendations from the World Professional Association for Transgender Health EMR Working Group.	J Am Med Inform Assoc	2013	1.23
8	Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066).	AIDS Res Hum Retroviruses	2015	1.08
9	Inclusion of trans women in pre-exposure prophylaxis trials: a review.	AIDS Care	2014	0.96
10	Laboratory-confirmed HIV and sexually transmitted infection seropositivity and risk behavior among sexually active transgender patients at an adolescent and young adult urban community health center.	AIDS Care	2015	0.91
11	Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots.	J Pharm Biomed Anal	2016	0.90
12	Syndemics and gender affirmation: HIV sexual risk in female-to-male trans masculine adults reporting sexual contact with cisgender males.	Int J STD AIDS	2015	0.89